We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
Cap. Flow
+$486M
Cap. Flow %
2.22%
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 10.43%
2 Financials 4.62%
3 Consumer Discretionary 4.22%
4 Healthcare 3.87%
5 Industrials 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKCC
3101
DELISTED
BlackRock Capital Investment Corporation
BKCC
$39K ﹤0.01%
11,994
-1,222
-9% -$4K
DHF
3102
BNY Mellon High Yield Strategies Fund
DHF
$176M
$38K ﹤0.01%
17,230
+456
+3% +$997
AGEN
3103
Agenus
AGEN
$315M
$36K ﹤0.01%
1,130
-116
-9% -$3.71K
ANNX icon
3104
Annexon
ANNX
$862M
$35K ﹤0.01%
10,000
RENT
3105
Rent the Runway
RENT
$122M
$32K ﹤0.01%
+806
New +$39.7K
OPTU
3106
Optimum Communications Inc
OPTU
$228M
$31K ﹤0.01%
10,327
WKHS icon
3107
Workhorse Group
WKHS
$33.1M
$31K ﹤0.01%
12
-2
-14% -$5.77K
QVCGA
3108
DELISTED
QVC Group Inc Series A
QVCGA
$31K ﹤0.01%
624
-287
-32% -$12.9K
BFX
3109
DELISTED
BowFlex Inc.
BFX
$31K ﹤0.01%
25,118
VAXX
3110
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$30K ﹤0.01%
12,011
+11
+0.1% +$23
GNSS icon
3111
Genasys
GNSS
$77.9M
$27K ﹤0.01%
10,410
ONDS icon
3112
Ondas Inc
ONDS
$5.08B
$27K ﹤0.01%
+31,385
New +$29.9K
DXYN
3113
DELISTED
Dixie Group Inc
DXYN
$27K ﹤0.01%
20,000
BBAI icon
3114
BigBear.ai
BBAI
$1.6B
$25K ﹤0.01%
+10,575
New +$26.8K
TPET icon
3115
Trio Petroleum
TPET
$10.8M
$25K ﹤0.01%
+750
New +$24.9K
NAK
3116
Northern Dynasty Minerals
NAK
$930M
$24K ﹤0.01%
98,160
+1,000
+1% +$228
SCWO icon
3117
374Water
SCWO
$44.6M
$24K ﹤0.01%
1,000
OMIC
3118
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$22K ﹤0.01%
878
GEVO icon
3119
Gevo
GEVO
$401M
$21K ﹤0.01%
13,748
+300
+2% +$388
SNDL icon
3120
Sundial Growers
SNDL
$311M
$21K ﹤0.01%
14,980
-2,000
-12% -$3.04K
AXDX
3121
DELISTED
Accelerate Diagnostics
AXDX
$20K ﹤0.01%
2,452
CLSD
3122
DELISTED
Clearside Biomedical
CLSD
$20K ﹤0.01%
1,167
HRTX icon
3123
Heron Therapeutics
HRTX
$63.5M
$20K ﹤0.01%
17,517
-500
-3% -$892
BRFS
3124
DELISTED
BRF SA
BRFS
$19K ﹤0.01%
+10,000
New +$15.4K
REFR icon
3125
Research Frontiers
REFR
$15.2M
$19K ﹤0.01%
12,166
-3,000
-20% -$4.85K

Similar funds

Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
  • Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
  • Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.